News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,308 Results
Type
Article (87459)
Company Profile (760)
Press Release (773068)
Multimedia
Podcasts (175)
Webinars (28)
Section
Business (233063)
Career Advice (4140)
Deals (39797)
Drug Delivery (138)
Drug Development (91257)
Employer Resources (203)
FDA (18285)
Job Trends (17402)
News (397417)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (126)
Alliances (56980)
ALS (146)
Alzheimer's disease (1683)
Antibody-drug conjugate (ADC) (251)
Approvals (18314)
Artificial intelligence (499)
Autoimmune disease (79)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (484)
Bladder cancer (135)
Brain cancer (53)
Breast cancer (513)
Cancer (4010)
Cardiovascular disease (340)
Career advice (3560)
Career pathing (38)
CAR-T (247)
CDC (57)
Cell therapy (688)
Cervical cancer (33)
Clinical research (75590)
Collaboration (1403)
Company closure (4)
Compensation (940)
Complete response letters (59)
COVID-19 (2959)
CRISPR (81)
C-suite (600)
Cystic fibrosis (138)
Data (4575)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (455)
Diagnostics (7095)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (237)
Drug pricing (191)
Drug shortages (36)
Duchenne muscular dystrophy (204)
Earnings (98874)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133083)
Executive appointments (994)
FDA (20783)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1268)
Gene editing (173)
Generative AI (50)
Gene therapy (548)
GLP-1 (1023)
Government (5386)
Grass and pollen (7)
Guidances (349)
Healthcare (20938)
HIV (48)
Huntington's disease (38)
IgA nephropathy (64)
Immunology and inflammation (244)
Immuno-oncology (21)
Indications (53)
Infectious disease (3205)
Inflammatory bowel disease (188)
Inflation Reduction Act (16)
Influenza (101)
Intellectual property (192)
Interviews (816)
IPO (17927)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (79)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (12)
Lung cancer (578)
Lymphoma (267)
Machine learning (31)
Management (66)
Manufacturing (644)
MASH (141)
Medical device (14878)
Medtech (14903)
Mergers & acquisitions (22754)
Metabolic disorders (1163)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (230)
Neuropsychiatric disorders (62)
Neuroscience (2728)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (58)
Obesity (562)
Opinion (314)
Ovarian cancer (135)
Pain (167)
Pancreatic cancer (172)
Parkinson's disease (243)
Partnered (30)
Patents (423)
Patient recruitment (322)
Peanut (57)
People (66288)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23314)
Phase II (32813)
Phase III (24722)
Pipeline (2748)
Policy (295)
Postmarket research (3554)
Preclinical (10513)
Press Release (72)
Prostate cancer (201)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (681)
Real estate (7422)
Recruiting (79)
Regulatory (28043)
Reports (65)
Research institute (2691)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (73)
Schizophrenia (137)
Series A (211)
Series B (158)
Service/supplier (30)
Sickle cell disease (81)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (96)
The Weekly (110)
Vaccines (1054)
Venture capital (67)
Weight loss (397)
Women's health (59)
Worklife (21)
Date
Today (143)
Last 7 days (750)
Last 30 days (2694)
Last 365 days (33622)
2025 (26844)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (304)
Arkansas (14)
Asia (51002)
Australia (8963)
California (9531)
Canada (2880)
China (914)
Colorado (405)
Connecticut (427)
Delaware (271)
Europe (117166)
Florida (1404)
Georgia (316)
Hawaii (3)
Idaho (67)
Illinois (813)
India (52)
Indiana (466)
Iowa (20)
Japan (327)
Kansas (124)
Kentucky (38)
Louisiana (21)
Maine (78)
Maryland (1288)
Massachusetts (7165)
Michigan (315)
Minnesota (566)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2650)
New Mexico (32)
New York (2594)
North Carolina (1420)
North Dakota (10)
Northern California (4329)
Ohio (300)
Oklahoma (22)
Oregon (50)
Pennsylvania (1983)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3637)
Tennessee (150)
Texas (1493)
United States (35224)
Utah (283)
Virginia (250)
Washington D.C. (84)
Washington State (823)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,308 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Alector Nearly Halves Workforce Following Dementia Drug Phase III Failure
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
October 23, 2025
·
74 min read
·
BioSpace Editorial Staff
Earnings
MASH, Metsera Deals Send Analysts Marauding to Viking
Viking Therapeutics CEO Brian Lian is watching the growth of interest in MASH and obesity but prepared to go it alone.
October 23, 2025
·
6 min read
·
Annalee Armstrong
Earnings
‘We’re Not Done’: Roche Plans To Sustain Dealmaking Pace After 89bio
Roche has already signed several high-ticket deals this year, including the $3.5 billion acquisition of 89bio and Genentech’s $2.1 billion molecular glue pact with Orionis Biosciences.
October 23, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH ELEMENT
How Supply Chain Turbulence Is Reshaping Biotech Strategy
In this episode presented by Element Materials Technology, guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney discuss how small biotechs face mounting pressure amid manufacturing uncertainties.
October 23, 2025
·
1 min read
·
BioSpace Insights
Cystic fibrosis
Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug
Despite showing no meaningful benefit on lung function, Arcturus’ mRNA therapy ARCT-032 reduced mucus volume in patients with cystic fibrosis—an outcome William Blair found “potentially promising.”
October 23, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Alkermes’ up to $2.1B Purchase of Avadel Sets Groundwork for ‘Strategic Evolution’
With Avadel under its fold, Alkermes expects to accelerate its expansion into the sleep market, laying the foundation for its late-stage narcolepsy asset alixorexton.
October 23, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Moderna Scraps CMV Vaccine After Phase III Fail
A key question for investors going forward will be whether Moderna’s other latent virus vaccines for Epstein-Barr and shingles can succeed after the failure of the CMV program.
October 23, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting
October 23, 2025
·
3 min read
Press Releases
Tango Therapeutics Announces $225 Million Financing
October 23, 2025
·
5 min read
Press Releases
Codexis to Report Third Quarter 2025 Financial Results on November 6
October 23, 2025
·
1 min read
1 of 86,131
Next
